- Home
- ETY vs VCEL Comparison
ETY vs VCEL Comparison
Compare ETY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETY
- VCEL
- Stock Information
- Founded
- ETY 2006
- VCEL 1989
- Country
- ETY United States
- VCEL United States
- Employees
- ETY N/A
- VCEL N/A
- Industry
- ETY Finance Companies
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ETY Finance
- VCEL Health Care
- Exchange
- ETY Nasdaq
- VCEL Nasdaq
- Market Cap
- ETY 2.1B
- VCEL 2.1B
- IPO Year
- ETY N/A
- VCEL 1997
- Fundamental
- Price
- ETY $14.28
- VCEL $41.87
- Analyst Decision
- ETY
- VCEL Strong Buy
- Analyst Count
- ETY 0
- VCEL 8
- Target Price
- ETY N/A
- VCEL $61.75
- AVG Volume (30 Days)
- ETY 247.3K
- VCEL 533.1K
- Earning Date
- ETY 01-01-0001
- VCEL 05-08-2025
- Dividend Yield
- ETY 7.21%
- VCEL N/A
- EPS Growth
- ETY N/A
- VCEL 521.85
- EPS
- ETY N/A
- VCEL 0.05
- Revenue
- ETY N/A
- VCEL $238,541,000.00
- Revenue This Year
- ETY N/A
- VCEL $23.23
- Revenue Next Year
- ETY N/A
- VCEL $24.41
- P/E Ratio
- ETY N/A
- VCEL $805.60
- Revenue Growth
- ETY N/A
- VCEL 14.80
- 52 Week Low
- ETY $10.59
- VCEL $37.39
- 52 Week High
- ETY $13.46
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ETY 59.27
- VCEL 52.07
- Support Level
- ETY $13.99
- VCEL $37.48
- Resistance Level
- ETY $13.86
- VCEL $39.42
- Average True Range (ATR)
- ETY 0.27
- VCEL 1.81
- MACD
- ETY 0.13
- VCEL 0.47
- Stochastic Oscillator
- ETY 94.95
- VCEL 92.37
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.